MAR 29, 2021 8:00 AM PDT

Design and performance characteristics of Alinity m Resp-4-Plex assay

Speakers

Abstract

Date:  March 29, 2021

Time: 8:00am PDT,  11:00am EDT

 

Influenza (Flu) and COVID-19 are both contagious respiratory illnesses, but they are caused by different viruses. COVID-19 is caused by infection with a new coronavirus (called SARS-CoV-2), and Flu is caused by infection with influenza viruses.1 Due to symptom similarities between Flu and COVID-19, testing is needed to help confirm a diagnosis.1  Being able to simultaneously identify patient’s infection status allows physicians the ability to provide optimal treatment decisions and control further disease transmission.  Alinity m Resp-4-Plex assay provides simultaneous qualitative detection and differentiation of Flu A, Flu B, Respiratory Syncytial Virus (RSV) and SARS-CoV-2 on the fully automated Alinity m system.  This webinar will discuss the design, development and clinical performance of the Alinity m Resp-4-Plex assay. 

 

Learning Objectives:

  • Discuss Respiratory Disease State and Current Trends Overview
  • Discuss the Alinity m Resp-4-Plex Assay Design
  • Discuss Alinity m Resp-4-Plex Assay Clinical Performance 

 

 

Webinars will be available for unlimited on-demand viewing after live event.

 

 


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
JUN 24, 2021 8:00 AM PDT
C.E. CREDITS
JUN 24, 2021 8:00 AM PDT
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...
Loading Comments...
Show Resources